Xencor, Inc. (XNCR)
11.93
+0.32
(+2.76%)
USD |
NASDAQ |
Feb 09, 16:00
11.93
0.00 (0.00%)
After-Hours: 20:00
Xencor EPS Diluted (Quarterly) : -0.081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
| MacroGenics, Inc. | 0.2658 |
| Bristol Myers Squibb Co. | 0.5326 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.027M |
| Revenue (Quarterly) | 21.00M |
| Total Expenses (Quarterly) | 27.03M |
| Enterprise Value | 560.44M |
| Gross Profit Margin (Quarterly) | 87.62% |
| Profit Margin (Quarterly) | -28.70% |
| Earnings Yield | -14.88% |
| Normalized Earnings Yield | -18.42 |